The CD40/CD40L costimulatory pathway in inflammatory bowel disease
- 1 July 2004
- Vol. 53 (7) , 1035-1043
- https://doi.org/10.1136/gut.2003.026278
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Cutting Edge: T Cells Trigger CD40-Dependent Platelet Activation and Granular RANTES Release: A Novel Pathway for Immune Response AmplificationThe Journal of Immunology, 2004
- CD40-mediated immune-nonimmune cell interactions induce mucosal fibroblast chemokines leading to T-Cell transmigrationGastroenterology, 2004
- Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactionsJournal of Clinical Investigation, 2003
- Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockadeNature Medicine, 2003
- Targeting of costimulatory molecules as a therapeutic approach in inflammatory bowel disease.BioDrugs, 2003
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002
- Studies on the interdependence of gp39 and B7 expression and function during antigen‐specific immune responsesEuropean Journal of Immunology, 1995
- Activation of human dendritic cells through CD40 cross-linking.The Journal of Experimental Medicine, 1994
- The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and deathCell, 1994
- Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help).The Journal of Experimental Medicine, 1992